stockrow
Saturday 7 November 2026
Export IBIO’s income statement to Excel — free account
iBio, Inc.
IBIO Healthcare Biotechnology
iBio, Inc.’s revenue for fiscal 2026 (year ended June 2026) was $100,000.00, down 75.0% from fiscal 2025.
- Revenue
- +100.0%
- EPS
- +80.5%
- Free cash flow
- −35.3%
Quarter to June 2026, against a year earlier
0.75
0.02
+2.74%
Follow IBIO
Alert me
| Jun '17 | Jun '18 | Jun '19 | Jun '20 | Jun '21 | Jun '22 | Jun '23 | Jun '24 | Jun '25 | Jun '26 | |
|---|---|---|---|---|---|---|---|---|---|---|
Piotroski F-Score |
2 | 3 | 2 | 3 | 3 | 3 | — | — | — | 4 |
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | 0.00 | 0.00 | 0.00 |
Altman Z-Score |
(3.11) | (3.34) | (6.14) | 0.24 | 3.08 | (3.00) | — | (16.05) | (21.93) | 2.80 |
P/S ratio |
88.10 | 20.87 | 6.57 | 85.11 | 124.60 | 27.63 | — | 3.80 | 12.77 | 269.79 |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | 0.00 | 0.00 | 0.00 |
Altman Z″-Score (non-manufacturers) |
(7.65) | (6.09) | (14.37) | (0.69) | 2.07 | (6.53) | — | (33.77) | (49.20) | (2.35) |
P/Operating CF |
(9.22) | (2.75) | (3.02) | (36.05) | (40.88) | (4.93) | — | (1.59) | (1.73) | (29.24) |
Beneish M-Score |
(4.15) | (3.26) | (0.48) | 64.75 | (1.87) | (1.94) | — | — | (3.22) | 33.49 |
P/B ratio |
3.89 | 0.57 | 5.40 | 2.46 | 2.72 | 0.89 | — | 0.36 | 0.54 | 2.12 |
Price to Tangible BV |
4.89 | 0.64 | 12.25 | 2.51 | 2.75 | 0.97 | — | 0.48 | 0.99 | 2.17 |
EV/Sales |
131.23 | 41.03 | 16.61 | 71.56 | 97.50 | 24.77 | — | (2.94) | 1.39 | 141.38 |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | 0.39 | 0.00 | 0.00 |
EV/Operating CF |
(3.93) | (1.35) | (2.40) | (8.78) | (7.69) | (1.36) | — | 0.32 | (0.06) | (4.11) |
EV/FCF |
(3.50) | (1.25) | (2.24) | (8.00) | (6.56) | (1.03) | — | 0.31 | (0.05) | (3.94) |
Quick Ratio |
4.10 | 7.87 | 1.31 | 11.60 | 15.43 | 1.30 | 0.34 | 4.07 | 1.42 | 7.59 |
Current Ratio |
4.26 | 8.00 | 1.39 | 11.79 | 15.74 | 1.48 | 1.19 | 4.08 | 1.59 | 7.85 |
Net Debt/EBITDA |
(1.36) | (0.73) | (1.46) | 1.89 | 2.26 | 0.31 | (0.23) | 0.89 | 0.44 | 2.57 |
Debt/Assets |
70.16% | 58.22% | 81.36% | 34.94% | 22.26% | 25.83% | 33.22% | 4.45% | 3.58% | 0.00% |
Debt/Equity |
2.83 | 1.55 | 10.13 | 0.58 | 0.30 | 0.40 | 0.89 | 0.06 | 0.06 | 0.00 |
Asset Turnover |
0.01 | 0.01 | 0.05 | 0.03 | 0.02 | 0.02 | 0.00 | 0.01 | 0.02 | 0.00 |
Operating CF/Net income |
0.90 | 0.82 | 0.78 | 0.35 | 1.28 | 0.74 | 0.47 | 0.74 | 0.83 | 0.70 |
Capex/Depreciation |
(0.95) | (0.63) | (0.57) | (0.51) | (1.96) | (2.76) | (1.86) | 0.66 | (0.01) | (0.69) |
Interest Coverage |
(7.40) | (7.43) | (8.31) | (5.68) | (12.68) | (167.78) | (353.53) | (96.71) | (87.75) | (663.04) |
| (88.73%) | (130.51%) | (191.75%) | (129.55%) | (28.41%) | (58.58%) | (164.86%) | (135.71%) | (101.52%) | (65.70%) | |
| (33.38%) | (41.38%) | (48.47%) | (61.33%) | (19.46%) | (40.91%) | (92.47%) | (71.22%) | (70.79%) | (54.04%) | |
ROIC |
(34.19%) | (35.13%) | (43.05%) | (25.44%) | (43.88%) | (33.36%) | (84.34%) | (135.39%) | (163.11%) | 0.00% |
Return on Tangible Assets |
(45.48%) | (41.53%) | (69.39%) | (63.59%) | (22.02%) | (314.81%) | (776.80%) | (161.06%) | (271.13%) | (39.54%) |
Average Days of Receivables |
162.12 | 61.66 | 17.54 | 1,253.21 | 850.69 | 1,181.79 | 0.00 | 1,156.64 | 95.81 | 4,029.60 |
Research and Development Expense of Revenue |
1,044.92% | 897.75% | 271.26% | 218.13% | 421.30% | 521.60% | 0.00% | 2,304.44% | 2,078.00% | 19,643.00% |
Selling, General and Administrative Expense of Revenue |
2,677.92% | 2,406.53% | 611.10% | 693.83% | 929.19% | 1,154.67% | 0.00% | 5,188.44% | 2,672.50% | 10,595.00% |
Intangible Assets out of Total Assets |
0.05 | 0.04 | 0.04 | 0.01 | 0.01 | 0.05 | 0.13 | 0.19 | 0.30 | 0.02 |
Share Based Compensation of Revenue |
256.35% | 173.42% | 11.94% | 23.69% | 66.89% | 232.32% | 0.00% | 905.78% | 382.50% | 1,373.00% |
Graham Net Nets |
(0.53) | (1.15) | (1.76) | 0.17 | 0.22 | 0.16 | — | 1.07 | 0.18 | 0.43 |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | 0.00 | 0.00 | 0.00 |
Earnings Yield |
(41.03%) | (166.85%) | (133.46%) | (38.64%) | (8.61%) | (87.75%) | — | (546.22%) | (235.43%) | (19.43%) |
Free Cash Flow Yield |
(42.51%) | (157.13%) | (112.82%) | (10.50%) | (11.92%) | (86.62%) | — | (247.80%) | (199.23%) | (13.30%) |
Revenue per Share |
22.13 | 20.85 | 53.25 | 13.04 | 6.06 | 4.32 | 0.00 | 0.06 | 0.04 | 0.00 |
Operating CF per Share |
(739.49) | (632.86) | (368.73) | (106.25) | (76.83) | (85.94) | (49.73) | (4.84) | (1.46) | (0.22) |
Capex per Share |
(89.49) | (50.66) | (26.12) | (9.19) | (13.19) | (26.67) | (5.13) | 0.24 | 0.00 | (0.01) |
Free Cash Flow per Share |
(828.99) | (683.52) | (394.85) | (115.44) | (90.02) | (112.61) | (54.86) | (4.61) | (1.46) | (0.23) |
Cash per Share |
454.38 | 748.08 | 116.65 | 438.79 | 247.83 | 76.87 | 11.97 | 3.90 | 0.82 | 0.85 |
Shareholders Equity per Share |
500.84 | 758.87 | 64.83 | 450.69 | 277.45 | 145.57 | 25.13 | 5.57 | 1.42 | 0.82 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
500.84 | 758.87 | 64.83 | 450.69 | 277.45 | 145.57 | 25.13 | 5.57 | 1.42 | 0.82 |
Free Cash Flow |
(14.76) | (14.56) | (14.96) | (14.50) | (35.23) | (49.11) | (33.57) | (17.65) | (15.32) | (23.80) |
Working Capital |
6.56 | 14.25 | 1.35 | 56.51 | 97.95 | 14.63 | 4.15 | 11.83 | 3.62 | 80.48 |
Capital Expenditures |
(1.59) | (1.08) | (0.99) | (1.15) | (5.16) | (11.63) | (3.14) | 0.91 | (0.02) | (0.58) |
Net Current Asset Value |
(18.52) | (10.63) | (23.32) | 24.17 | 66.20 | 9.15 | 0.43 | 8.26 | 1.42 | 78.82 |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | 0.36 | 0.00 | 0.00 |
Capex to Sales |
4.04 | 2.43 | 0.49 | 0.70 | 2.18 | 6.17 | 0.00 | (4.03) | 0.04 | 5.78 |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | 0.00 | 0.00 | 0.00 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.07 | 0.07 | 0.07 | 0.61 | 0.30 | 3.07 | 0.40 | 0.38 | 0.36 | 0.27 |
Cash ROIC |
(34.91%) | (25.46%) | (47.12%) | (10.03%) | (14.78%) | (40.03%) | (92.25%) | (47.03%) | (63.07%) | (13.70%) |
Accounts Receivable Turnover |
1.01 | 3.55 | 23.47 | 0.57 | 0.43 | 0.32 | 0.00 | 0.49 | 0.98 | 0.17 |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.51 | 0.73 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Inventory Turnover |
0.00 | 0.00 | — | 1.71 | 3.54 | 0.00 | 0.00 | — | — | — |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 913.28 | 562.73 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Days of Inventory on Hand |
0.00 | 0.00 | — | 414.32 | 6.74 | 375.49 | 0.00 | — | — | — |
Average Receivables |
0.39 | 0.13 | 0.09 | 2.86 | 5.58 | 5.81 | 3.15 | 0.46 | 0.41 | 0.60 |
Average Payables |
0.96 | 0.77 | 0.90 | 1.38 | 2.01 | 3.26 | 3.06 | 1.10 | 1.27 | 3.31 |
Average Inventory |
0.02 | 0.03 | — | 0.41 | 0.41 | 1.96 | — | — | — | — |
Average Assets |
43.81 | 39.55 | 36.83 | 62.39 | 120.58 | 123.19 | 70.31 | 34.97 | 25.96 | 61.15 |
Average Common Equity |
16.48 | 12.54 | 9.31 | 29.53 | 82.59 | 86.03 | 39.43 | 18.35 | 18.10 | 50.30 |
Columns are period end dates · fundamentals updated 26 Oct 2026